COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2412: Articles 24111-24120  | Next

Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
Ong, E., Huang, X., Pearce, R., Zhang, Y., He, Y.
10.1101/2020.08.14.251496 — Posted: 2020-08-14
In Silico Design of siRNAs Targeting Existing and Future Respiratory Viruses with VirusSi
Zhang, D., Lu, J.
10.1101/2020.08.13.250076 — Posted: 2020-08-14
Differential methylation as a mediator of COVID-19 susceptibility
Steyaert, S., Trooskens, G., Delanghe, J. R., Van Criekinge, W.
10.1101/2020.08.14.251538 — Posted: 2020-08-14
Pandemic danger to the deep: the risk of marine mammals contracting SARS-CoV-2 from wastewater
Mathavarajah, S., Stoddart, A. K., Gagnon, G. A., Dellaire, G.
10.1101/2020.08.13.249904 — Posted: 2020-08-14 Discussion: Onsite
Methylation of RNA Cap in SARS-CoV-2 captured by serial crystallography
Wilamowski, M., Sherrell, D., Minasova, G., Kim, Y., Shuvaloca, L., Lavens, A., Chard, R., Maltseva, N., Jedrzejczak, R., Rosas-Lemus, M., Saint, N., Foster, I. T., Michalska, K., Satchell, K. J., Joachimiak, A.
10.1101/2020.08.14.251421 — Posted: 2020-08-14 Discussion: Onsite
SARS-CoV-2 manipulates the SR-B1-mediated HDL uptake pathway for its entry
Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Zhang, Y., Sun, J., Yang, X., Gong, J., Fan, C., Yang, X., Wang, Y., Wang, X., Li, J., Yang, H., Li, H., Zhang, Z., Wang, R., Du, P., Zong, Y., Yin, F., Zhang, W., Peng, Y., Lin, H., Zhang, R., Chen, W., Gao, Q., Cao, Y., Zhong, H.
10.1101/2020.08.13.248872 — Posted: 2020-08-14 Discussion: Onsite | Offsite
SARS-CoV-2 Infection And Longitudinal Fecal Screening In Malayan Tigers (Panthera tigris jacksoni), Amur Tigers (Panthera tigris altaica), And African Lions (Panthera leo krugeri) At The Bronx Zoo, New York, USA
Bartlett, S. L., Diel, D. G., Wang, L., Zec, S., Laverack, M., Martins, M., Caserta, L. C., Killian, M. L., Terio, K., Olmstead, C., Delaney, M. A., Stokol, T., Ivancic, M., Jenkins-Moore, M., Ingerman, K., Teegan, T., McCann, C., Thomas, P., McAloose, D., Sykes, J. M., Calle, P. P.
10.1101/2020.08.14.250928 — Posted: 2020-08-14
COVID-19 vaccination intention in the UK: Results from the COVID-19 Vaccination Acceptability Study (CoVAccS), a nationally representative cross-sectional survey
Sherman, S. M., Smith, L. E., Sim, J., Amlot, R., Cutts, M., Dasch, H., Rubin, G. J., Sevdalis, N.
10.1101/2020.08.13.20174045 — Posted: 2020-08-14
Hospital preparedness in epidemics by using simulation. The case of COVID-19
Garcia-Vicuna, D., Esparza, L., Mallor, F.
10.1101/2020.08.12.20173328 — Posted: 2020-08-14
Examining face-mask usage as an effective strategy to control COVID-19 spread
Catching, A., Capponi, S., Yeh, M. T., Bianco, S., Andino, R.
10.1101/2020.08.12.20173047 — Posted: 2020-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).